LISA FRITCH: Open Payments
NPI 1770545261 · BLOOMFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 51 payments from 17 companies in 2025. Trend: 2023 $785 · 2024 $2,216 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $277 |
| Abbott Laboratories | 2 | $170 |
| Medtronic, Inc. | 1 | $159 |
| Edwards Lifesciences Corporation | 1 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $140 |
| Novo Nordisk Inc | 5 | $130 |
| Amgen Inc. | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 5 | $84 |
| PFIZER INC. | 3 | $73 |
| ABIOMED | 2 | $67 |
Products named: LEQVIO, SYMPLICITY G3, CARDIOMEMS, JARDIANCE, REPATHA, Wegovy, VYNDAQEL, CAMZYOS.
Industry payments across CT — which companies pay providers there.
